Presentation VerifyNow in DIabetes High On-Treatment Platelet Reactivity: Switching from Clopidogrel to Prasugrel Presenter: J.M. Cubero October 06, 2014
News Daily News Subanálisis del PLATO: Las Hemorragias Graves se asocian a una Mayor Mortalidad a Corto Plazo en el Manejo de los SCA Yael L. Maxwell October 03, 2014
News Daily News Registro MARIS: El Stent de Nitinol Parece Seguro y Efectivo en Pacientes AFS del ‘Mundo Real’ October 03, 2014
News Daily News Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable L.A. McKeown October 03, 2014
News Daily News PLATO Subanalysis: Major Bleeding Linked With Increased Short-term Mortality in ACS Yael L. Maxwell October 03, 2014
News Daily News MARIS Registry: Nitinol Stent Appears Safe, Effective in ‘Real World’ SFA Patients October 03, 2014
News Daily News CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients L.A. McKeown October 03, 2014
News Daily News Las Directrices 2014 para el Manejo de SCASEST tienen un Nuevo Nombre y Objetivo September 30, 2014
Presentation TCT 2014 Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS Presenter: Timothy Henry September 16, 2014
Presentation TCT 2014 Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study Presenter: Armando P?rez de Prado September 16, 2014
Presentation TCT 2014 VerifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)_ Presenter: Jos? Mar?a Cubero G?mez September 16, 2014
Presentation TCT 2014 Impact of platelet reactivity on clopidogrel after PCI with 2nd generation DES on late lumen loss_ Presenter: Naoei Isomura September 16, 2014
Presentation TCT 2014 Comparable outcomes on single use of clopidogrel vs_ dual antiplatelet therapy after coronary stenting in patients with acute myocardial infarction Presenter: Jun-Hyok Oh September 16, 2014
Presentation TCT 2014 Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy Presenter: Dietmar Trenk September 16, 2014
News Conference News TCT 2014 PRIMA: PFO Closure Fails to Reduce Number of Migraine Days at 1 Year Yael L. Maxwell September 16, 2014
Presentation TCT 2014 TRANSLATE-ACS: A Large-Scale Registry Comparing Patterns of Use and One-Year Outcomes with Prasugrel Versus Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Presenter: Stefan K. James, Cindy L. Grines, Tracy Y. Wang September 15, 2014
Presentation TCT 2014 ISAR-TRIPLE: A Prospective, Randomized Trial of Six Weeks Versus Six Months of Clopidogrel in Patients Treated with Concomitant Aspirin and Oral Anticoagulant Therapy Following Coronary Drug-Eluting Stent Implantation Presenter: Roxana Mehran, Harvey D. White, Nikolaus Sarafoff September 15, 2014
News Conference News TCT 2014 PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI September 15, 2014
News Industry News New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation September 15, 2014